Acne Drugs Market accounted 12281.2 million USD in 2020 and is expected to reach 17323.9 million USD by 2030 growing with a CAGR of 3.50% during the forecast period. Acne is caused majorly due to excess oil formed by glands on skin which leaves mark or scar on the skin. Face, shoulder, neck, and chest are the place where acne usually appears. It is an inflammatory and chronic skin disease. Acne is a dermatological condition disturbing more than 9.4million across the world. Whiteheads, blackheads, pimples, cysts, and nodules are the results of acne. The cellular wall breaks, due to growth in oil glands under the skin that leads to acne. Lack of sleep, smoking, drug misuse, emotional and work-related stress, and alcohol consumption are major activates that causes acne. Among teenagers and adults. Acne treatment depends on the skin type and the seriousness of the condition. Permanent cure to the problems caused by the acne is offered by laser treatment which prevents future pigmentation issues.

Market Segmentation:

The global acne drugs market is segmented on basis of type into comedonal, inflammatory, cystic, and postsurgical. According to route of administration, the market is divided into opical, oral, inject able. On the basis of therapeutic class, the global acne drugs market is categorized into retinoid, antibiotic, hormonal agent, combination and others. By region the acne drugs market is classified into North America, Europe, Asia-Pacific, and RoW.

Market Dynamics and Factors:

Acne is one of the most common dermatological diseases across the globe. 90% of people suffer from sort of acne. In US, almost 12million people suffer from a severe acne problem, which can lead to scarring of the skin if left untreated, as a result of this; maximum people purchase acne care drugs and products owing to, this will drive the market worldwide. The treatment like algorithm, combinational therapies are gaining popularity from last few years. On the other hand, the presence of alternatives like surgeries, home remedies, laser treatment, photodynamic therapy etc for acne treatment is one of the restraints on the acne drugs market. Due to availability of multiple alternatives, people are moving to choose one amongst many options on the basis of price, side effects, duration and many more. Adverse side effect of drug such as birth defects, high blood pressure, nausea etc is restraining the acne drugs market.

Geographic Analysis:

North America is the dominating region in the acne drugs market. This region is expected to hold the position during the next five years. Among the countries, the U.S. acne drugs market is the largest. The growth in the region will be majorly driven by rising disease incidence, lifestyle changes, and easy availability of products. Asia-pacific is forecasted to register the highest CAGR during forecast period. Owing to high population base, rise in disposable income resulting to the improvement in patient awareness about acne drugs.

Competitive Scenario:

The major player  in the global acne drugs market such as Allergan, S.A. Valeant Pharmaceutical GlaoSmithKline Plc, Bayer AG, Stiefel laboratories Inc, Ranbaxy laboratories limited, Pfizer Inc, Mylan N.V., Cipher, Daiichi sankyo company Ltd, Guthy -Renker LLC, Medicis Pharmaceutical Corporation, Foamix  Pharmaceuticals, BioPharmaX ,Roche Holding AG, Anterios Inc, AndroScience, Oculus innovative Sciences, Aqua Pharmaceuticals, Prestium Pharma Inc.

Acne Drugs Market Report Scope